Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4CAST: Seviteronel + Dexamethasone + Docetaxel in Metastatic Breast Cancer
NCT04947189Phase 2Recruiting
- Sponsor
- St Vincent's Hospital
- Start
- Nov 2022
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of seviteronel in triple-negative breast cancer (TNBC), breast cancer, sponsored by St Vincent's Hospital. Started Nov 2022; status: recruiting.
02
Drugs
seviteronel
03
Conditions
triple-negative breast cancer (TNBC)breast cancer
Beyond the preview
Go deeper on NCT04947189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04947189.